Terrance P. Coyne

EVP & CFO, Royalty Pharma plc

Bought, 12 months

$0.0M

Sold, 12 months

$39.0M

Companies

Latest trade

Aug 13, 2026

Companies

Royalty Pharma plcEVP & CFO −$39.0M

Trades

RPRX Sold 11,002 shares at $58.68 · planned $0.6M Aug 13

RPRX Sold 64,399 shares at $53.98 · planned $3.5M May 26

RPRX Sold 34,791 shares at $49.78 · planned $1.7M Apr 28

RPRX Sold 34,791 shares at $48.33 · planned $1.7M Apr 1

RPRX Sold 34,791 shares at $45.53 · planned $1.6M Mar 23

RPRX Sold 34,791 shares at $46.78 · planned $1.6M Mar 2

RPRX Sold 34,791 shares at $45.32 · planned $1.6M Feb 23

RPRX Sold 20,163 shares at $43.29 · planned $0.9M Feb 4

RPRX Sold 114,954 shares at $42.84 · planned $4.9M Feb 3

RPRX Sold 108,424 shares at $42.08 · planned $4.6M Feb 2

RPRX Sold 69,582 shares at $39.35 · planned $2.7M Jan 20

RPRX Sold 69,582 shares at $38.42 · planned $2.7M Jan 2

RPRX Sold 69,582 shares at $38.36 · planned $2.7M Dec 15

RPRX Sold 69,582 shares at $39.87 · planned $2.8M Dec 1

RPRX Sold 69,582 shares at $38.55 · planned $2.7M Nov 24

RPRX Sold 69,594 shares at $39.30 · planned $2.7M Nov 17

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.